Intuitive Surgical, Inc. $ISRG Shares Purchased by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 135,757 shares of the medical equipment provider’s stock after purchasing an additional 3,950 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Intuitive Surgical were worth $59,861,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Tobam grew its stake in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $27,000. Princeton Global Asset Management LLC purchased a new stake in shares of Intuitive Surgical in the second quarter valued at approximately $30,000. Riggs Asset Managment Co. Inc. increased its holdings in shares of Intuitive Surgical by 84.2% in the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after purchasing an additional 32 shares during the last quarter. Finally, First Command Advisory Services Inc. lifted its position in Intuitive Surgical by 3,750.0% during the second quarter. First Command Advisory Services Inc. now owns 77 shares of the medical equipment provider’s stock worth $42,000 after buying an additional 75 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 750 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $435,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Mark Brosius sold 464 shares of the company’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $548.49, for a total value of $254,499.36. Following the sale, the senior vice president directly owned 131 shares in the company, valued at $71,852.19. This represents a 77.98% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 114,007 shares of company stock worth $63,533,844 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts have recently commented on ISRG shares. The Goldman Sachs Group reiterated a “buy” rating and set a $714.00 price target on shares of Intuitive Surgical in a report on Friday, January 9th. Raymond James Financial set a $603.00 target price on shares of Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. HSBC raised their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Jefferies Financial Group upped their price objective on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a report on Wednesday, October 22nd. Finally, Mizuho set a $575.00 target price on Intuitive Surgical in a research note on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $622.17.

Intuitive Surgical Trading Down 1.1%

Intuitive Surgical stock traded down $5.98 during midday trading on Tuesday, reaching $529.02. 177,693 shares of the stock traded hands, compared to its average volume of 1,848,869. The firm has a market cap of $189.64 billion, a PE ratio of 70.13, a price-to-earnings-growth ratio of 4.35 and a beta of 1.67. The company has a 50-day simple moving average of $565.50 and a two-hundred day simple moving average of $511.79. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the prior year, the company earned $1.84 earnings per share. The business’s quarterly revenue was up 22.9% on a year-over-year basis. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.